Hypertension: Which aspects of hypertension should we impact on and how?

Journal of Hypertension

Volumn 24, Issue SUPPL. 5, 2006, Pages

  Zanchetti, Alberto ^a,c   Waeber, Bernard ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Serv d'Hypertension Med Vasculaire   (Switzerland)

^c Centro di Fisiologia Clinica e Ipertensione   (Italy)

Author keywords

Antihypertensive therapy; Combination therapy; Indapamide; Perindopril; Systolic blood pressure

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOSARTAN; PERINDOPRIL; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; ARTERIOLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CAPILLARY FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; HUMAN; HYPERTENSION; KIDNEY DISEASE; LOW DRUG DOSE; MICROCIRCULATION; MONOTHERAPY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 33748032105     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000240039.97472.f1     Document Type: Review

References (11)

1. Zanchetti A, Blood pressure: from systolic to diastolic and back to systolic values as guides to prognosis and treatment. In: Birkenhager WH, Robertson JIS, Zanchetti A, editors.: Hypertension in the twentieth century: concepts and achievements. Handbook of Hypertension, 23. Amsterdam: Elsevier BV; 2004. p. 143-150.
2. Pickering G. High blood pressure, 2nd ed. New York: Grune and Stratton; 1968.
3. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103:1245-1249.
4. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure - factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594-599.
5. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
6. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002; 20:1461-1464.
7. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363:2022-2031.
8. Morgan TO, Anderson AIE, MacInnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001; 14:241-247.
9. Mourad JJ, Waeber B, Zannad F, Laville M, Duru G, Andrejak M. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens 2004; 22:2379-2386.
10. Waeber B, Mourad JJ. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension. Am J Hypertens 2006; in press.
11. Haute Autorité de Santé. Prise en charge des patients adultes atteints d'hypertension artérielle essentielle - Recommendations (Management of adult patients with essential arterial hypertension. Recommendations). 2005 Update. Available at: http://www.sfhta.org/pdf/ 2RecoHTA2005.pdf. Accessed: July 2006